Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-05-09
1993-08-24
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514925, 530323, 530338, 530824, 530416, 530417, 530412, 530300, 530371, A61K 3702, C07K 302, C07K 1500
Patent
active
052389251
ABSTRACT:
Disclosed herein is purified isolated angiogenic factor, isolated from Live Yeast Cell Derivative. Also disclosed herein are methods to treat mammals suffering from wounds or burns comprising administering the angiogenic factor and pharmaceutical formulations for use in the methods.
REFERENCES:
patent: 2239345 (1941-04-01), Sperti
patent: 2320478 (1943-06-01), Sperti
patent: 4284552 (1981-08-01), Bucovaz
patent: 4575457 (1986-03-01), Mazarin
patent: 4707542 (1987-11-01), Friedman
patent: 4942031 (1990-07-01), Levin
Goodson et al., J. Surge. Res. 21:125-129, 1976.
Subramanyam et al., Digestive Diseases and Sciences 29:829-832, 1984.
Kaplan, Arch. Surge. 119:1005-1008, 1984.
Hunt et al., Inflammation and wound Healing, 96:48-54, 1984.
Banda et al., Proc. Natl. Acad. Sci. USA, 79:7773-7777, 1982.
Vu et al., Laboratory Investigation, 53:499-508, 1985.
Dusseau et al., Circ. Res., 59:163-170, 1986.
Bentley et al. Arch. Surge. 125:641-648, 1990.
Moezie F. T.
The State of Oregon Acting by and through The State Board of Hig
LandOfFree
Angiogenic factor isolated from live yeast cell derivatives and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiogenic factor isolated from live yeast cell derivatives and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenic factor isolated from live yeast cell derivatives and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829306